Mesahenz 400mg Strip Of 10 Tablets
10 Tablet(s) in StripMRP ₹83.92
₹67.98
19% OFF
Made by
LA RENON HEALTHCARE PVT LTD
Dosage
TABLET
Expiry
Product Summary
| Salt Content | Mesalazine / Mesalamine / 5-Aminosalicylic Acid(400.0 Mg) |
| Uses | Treatment of mild to moderate Ulcerative colitis |
| Therapy | Drugs for ulcerative colitis |
| Side effects | Nausea, Vomiting, Diarrhoea, Abdominal pain, Constipation, Headache, Muscle Pain |
Assurance
available
Regulated
Medical Description
Uses
- As per CDSCO, Mesahenz Tablet is used for the Treatment of mild to moderate Ulcerative colitis
Contraindications
- If you have an allergic reaction to ingredients of Mesahenz Tablet, i.e., Mesalazine.
- If you have intestinal blockage or obstruction in any part of your digestive tract.
- If you have any liver or kidney-related impairment or diseases.
- If you have a rare blood condition called porphyria.
- If your child is below the age of 5 years.
- If you are pregnant or breastfeeding.
Side effects
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Constipation
- Headache
- Muscle Pain
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You are using any ayurvedic medicines, vitamins, and other health supplements.
- You have any allergic reactions after taking the Mesahenz Tablet.
- You notice tightness in the chest or throat
- You have trouble breathing or talking
- You have watery diarrhoea or fever.
- You experience black tarry stools and abdominal pain after taking Mesahenz Tablet.
- Your symptoms didn’t resolve, or your condition worsened.
- You have kidney or liver-related disease or kidney failure.
- You are breastfeeding or pregnant.
Directions for Use
- Take the Mesahenz Tablet exactly as directed by your doctor.
- Take the Mesahenz Tablet with a meal or as advised by the doctor.
- Swallow Mesahenz Tablet with a glass of water. Do not split, chew, or crush it.
- Do not take Mesahenz Tablet with other medications without consulting your doctor.
- Don’t exceed the recommended dosage of Mesahenz Tablet, even if you cannot feel its effects.
Storage and disposal
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
- Certain medicines can interfere with the action of Mesahenz Tablet, or this tablet itself can affect the action of other medicines taken at the same time. Always inform your doctor about all the medicine you are taking, which includes all prescribed or non-prescribed herbal medicines, dietary supplements, etc.
- The concurrent use of Mesahenz Tablet with known nephrotoxic agents may increase the risk of nephrotoxicity and lead to kidney failure.
- The concurrent use of Mesahenz Tablet with azathioprine or 6-mercaptopurine (used in rheumatoid arthritis, Crohn's disease) and any other medicines which are known to cause myelotoxicity may increase the risk for blood disorders, bone marrow failure, and associated complications.
- Mesahenz Tablet, when taken along with blood thinners like warfarin (used to prevent blood clot formation), may decrease the effect of warfarin.
Interactions with food items
- Avoid consuming nicotine, caffeine (coffee, tea, chocolate, and cola), alcohol, and spicy, oily, fried, and junk food while taking Mesahenz Tablet, as it can stimulate stomach acid or delay healing and hinder the treatment process.
Frequently Asked Questions (FAQs)
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:MESAHENZ
Manufacturer Name:LA RENON HEALTHCARE PVT LTD
Address:Stanford Laboratories Pvt Ltd . 8 Industrial Area Mehatpur Distt Una ( H P) 174319
Country of Origin:India
Vendor Details
Fulfillment Information: Mesahenz 400 MG Tablet (10) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- Raffi Karagozian R. The role of mesalamine in the treatment of ulcerative colitis [Internet]. PubMed Central (PMC). 2022 [cited 29 March 2022].
- Ham M, Moss A. Mesalamine in the treatment and maintenance of remission of ulcerative colitis. Expert Review of Clinical Pharmacology [Internet]. 2012 [cited 29 March 2022].
- Nakashima J, Preuss C. Mesalamine (USAN) [Internet]. Statpearls.com. 2022 [cited 29 March 2022].
- National Health Service (NHS). Mesalazine [Internet]. London (UK): NHS; [cited 2025 Oct 27].
- DailyMed - LIALDA- mesalamine tablet, delayed release [Internet]. Dailymed.nlm.nih.gov. 2022 [cited 29 March 2022].
- Drugs H. Mesalamine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2022 [cited 29 March 2022].
- Central Drugs Standard Control Organisation. New Drugs – CDSCO [Internet]. New Delhi (IN): CDSCO; [cited 2025 Oct 27].
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.





















